you are here: home > research a topic > find web sites on your topic > Hormone Replacement Therapy
|
|
|
|
|
Estrogen Plus
Progestin Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall
Benefit
from the National Heart, Lung and Blood Institute, who ran the clinical trial.
This trial was a part of the Women's Health Initiative. The study was
stopped due to an increased risk of invasive breast cancer and increases in
coronary heart disease, stroke, and pulmonary embolism in study participants on
estrogen plus progestin compared to women taking placebo pills.
Risks and
Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women
from the Journal of the American Medical Association. Full text of the
report in the July 2002 issue of JAMA from the Women's Health Initiative
Randomized Controlled Trial.
Questions and Answers: Use of Hormones After Menopause
from the National Cancer Institute. The NCI's response to the Women's
Health Initiative's findings.
The North American Menopause
Society's Response
The North American Menopause Society (NAMS) is North America's leading nonprofit
organization dedicated to promoting women's health during midlife and beyond
through an understanding of menopause. The press release section of their
website has the most up-to-date response to the Women's Health Initiative study.
Copyright 2001, (written, graphic and pictorial material) Highland Park Public Library, Highland Park, Illinois. Permission for reproduction of any material included on this website must be obtained from the Library.
E-mail comments or corrections to hpplweb@nsls.info